Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE

Identifieur interne : 00A972 ( Main/Exploration ); précédent : 00A971; suivant : 00A973

A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE

Auteurs : Paul Kiritze Topor [France] ; Dominique Huas [France] ; Claude Rosenzweig [France] ; Sylvie Comte [France] ; Franc Ois Paille [France] ; Philippe Lehert [Australie]

Source :

RBID : ISTEX:3BAAC4FBA10894F7FB78A0A7DCD72E3AF5A37F3F

Descripteurs français

English descriptors

Abstract

Aims: To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treated in a naturalistic setting in primary care in France. Methods: The ARES (Acamprosate et Répercussions Économiques et Sociales; Acamprosate and Economic and Social Repercussions) study was performed by 149 general practitioners interested in treating alcohol use disorders in France who included patients fulfilling DSM-IV criteria for alcohol dependence. The only exclusion criteria concerned contra-indications to acamprosate, co-medication with naltrexone and multiple substance abuse. Eligible patients were randomized to one of two treatment arms, either standard care alone or standard care with acamprosate, using an open-label design and followed up quarterly for a period of 1 year. The primary outcome variable was the change from baseline on the Alcohol-Related Problems Questionnaire. Secondary efficacy variables were abstinence, Clinical Global Impression, quality of life measured with the SF-36 and incidence of adverse events. An intent-to-treat population was used for outcome analysis. Results: 422 patients were included, of whom 348 (82%) completed the protocol as planned. At the end of the study, patients randomized to the acamprosate group had significantly better outcomes in terms of total ARPQ score, change from baseline (−2.61 vs −3.44) and number of subjects with no alcohol-related problem. On average, patients treated with acamprosate had one less alcohol-related problem than did the controls. The number needed to treat in order to save one additional patient from alcohol-related problems compared to standard care was 7.14. Statistically significant differences in favour of the acamprosate group were observed for all secondary efficacy outcome measures including quality of life. Conclusions: Adjunctive therapy with acamprosate in primary care is associated with significantly better functional outcome. Pragmatic trials in alcohol dependence are both feasible and informative.

Url:
DOI: 10.1093/alcalc/agh088


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE</title>
<author>
<name sortKey="Kiritze Topor, Paul" sort="Kiritze Topor, Paul" uniqKey="Kiritze Topor P" first="Paul" last="Kiritze Topor">Paul Kiritze Topor</name>
</author>
<author>
<name sortKey="Huas, Dominique" sort="Huas, Dominique" uniqKey="Huas D" first="Dominique" last="Huas">Dominique Huas</name>
</author>
<author>
<name sortKey="Rosenzweig, Claude" sort="Rosenzweig, Claude" uniqKey="Rosenzweig C" first="Claude" last="Rosenzweig">Claude Rosenzweig</name>
</author>
<author>
<name sortKey="Comte, Sylvie" sort="Comte, Sylvie" uniqKey="Comte S" first="Sylvie" last="Comte">Sylvie Comte</name>
</author>
<author>
<name sortKey="Paille, Franc Ois" sort="Paille, Franc Ois" uniqKey="Paille F" first="Franc Ois" last="Paille">Franc Ois Paille</name>
</author>
<author>
<name sortKey="Lehert, Philippe" sort="Lehert, Philippe" uniqKey="Lehert P" first="Philippe" last="Lehert">Philippe Lehert</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3BAAC4FBA10894F7FB78A0A7DCD72E3AF5A37F3F</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1093/alcalc/agh088</idno>
<idno type="url">https://api.istex.fr/document/3BAAC4FBA10894F7FB78A0A7DCD72E3AF5A37F3F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B16</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B16</idno>
<idno type="wicri:Area/Istex/Curation">000B16</idno>
<idno type="wicri:Area/Istex/Checkpoint">001A50</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A50</idno>
<idno type="wicri:doubleKey">0735-0414:2004:Kiritze Topor P:a:pragmatic:trial</idno>
<idno type="wicri:Area/Main/Merge">00B629</idno>
<idno type="wicri:Area/Main/Curation">00A972</idno>
<idno type="wicri:Area/Main/Exploration">00A972</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE</title>
<author>
<name sortKey="Kiritze Topor, Paul" sort="Kiritze Topor, Paul" uniqKey="Kiritze Topor P" first="Paul" last="Kiritze Topor">Paul Kiritze Topor</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>11 avenue du Grain d'Or, 49600 Beaupreau</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Pays de la Loire</region>
<settlement type="city">Beaupreau</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">France</country>
<wicri:regionArea>Author to whom correspondence should be addressed at: 11 avenue du Grain d'Or 49600 Beaupréau</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Huas, Dominique" sort="Huas, Dominique" uniqKey="Huas D" first="Dominique" last="Huas">Dominique Huas</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of General Practice, Xavier Bichat University, 75018 Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rosenzweig, Claude" sort="Rosenzweig, Claude" uniqKey="Rosenzweig C" first="Claude" last="Rosenzweig">Claude Rosenzweig</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Le Clos Macé, 35850 Geveze</wicri:regionArea>
<wicri:noRegion>35850 Geveze</wicri:noRegion>
<wicri:noRegion>35850 Geveze</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Comte, Sylvie" sort="Comte, Sylvie" uniqKey="Comte S" first="Sylvie" last="Comte">Sylvie Comte</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Merck Santé, 37 rue Saint-Romain, 69379 Lyon cedex 08</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Paille, Franc Ois" sort="Paille, Franc Ois" uniqKey="Paille F" first="Franc Ois" last="Paille">Franc Ois Paille</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Villemin, 17 rue de Nabecor, 54000 Nancy</wicri:regionArea>
<placeName>
<settlement type="city">Nancy</settlement>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lehert, Philippe" sort="Lehert, Philippe" uniqKey="Lehert P" first="Philippe" last="Lehert">Philippe Lehert</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Statistics Department, University of Mons, FuCam, Mons, Belgium and Faculty of Medicine, University of Melbourne, Melbourne</wicri:regionArea>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Alcohol and Alcoholism</title>
<title level="j" type="abbrev">Alcohol and Alcoholism</title>
<idno type="ISSN">0735-0414</idno>
<idno type="eISSN">1464-3502</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2004-NaN">2004-NaN</date>
<biblScope unit="volume">39</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="520">520</biblScope>
<biblScope unit="page" to="527">527</biblScope>
</imprint>
<idno type="ISSN">0735-0414</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0735-0414</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Abstinence</term>
<term>Academic centres</term>
<term>Acamprosate</term>
<term>Acamprosate group</term>
<term>Acute detoxification</term>
<term>Additional patient</term>
<term>Adjunctive therapy</term>
<term>Adverse event</term>
<term>Alcohol</term>
<term>Alcohol alcoholism</term>
<term>Alcohol consumption</term>
<term>Alcohol dependence</term>
<term>Alcohol misuse</term>
<term>Alcoholdependent patients</term>
<term>Alcoholdependent subjects</term>
<term>Alcoholism</term>
<term>Ares</term>
<term>Ares study</term>
<term>Arpq</term>
<term>Arpq score</term>
<term>Baseline</term>
<term>Baseline score</term>
<term>Baseline variables</term>
<term>Better outcome</term>
<term>Bodily pain</term>
<term>Clinical effectiveness</term>
<term>Clinical trial methodology</term>
<term>Clinical trials</term>
<term>Community care</term>
<term>Confidence limits</term>
<term>Control group</term>
<term>Cumulative abstinence duration</term>
<term>Cumulative abstinence duration proportion</term>
<term>Detoxification</term>
<term>Diagnostic criteria</term>
<term>Drink diaries</term>
<term>Drinking behaviour</term>
<term>Drinking history</term>
<term>Employment situation</term>
<term>Entry criteria</term>
<term>Everyday practice</term>
<term>Exclusion criteria</term>
<term>Experimental research</term>
<term>Familial antecedents</term>
<term>French version</term>
<term>General population</term>
<term>General practice</term>
<term>General practitioner</term>
<term>General practitioners</term>
<term>Health problems</term>
<term>Health profile measure</term>
<term>Health transition</term>
<term>Inclusion</term>
<term>Inclusion bias</term>
<term>Investigator</term>
<term>Less problem</term>
<term>Medical care</term>
<term>Mental health</term>
<term>Multiple regression analysis</term>
<term>Neat study</term>
<term>Other hand</term>
<term>Outcome criteria</term>
<term>Outcome measure</term>
<term>Outcome measures</term>
<term>Patient characteristics</term>
<term>Patients consulting</term>
<term>Patients randomized</term>
<term>Placebo group</term>
<term>Possible scores</term>
<term>Potential source</term>
<term>Potential sources</term>
<term>Practitioner</term>
<term>Pragmatic</term>
<term>Pragmatic trial</term>
<term>Pragmatic trials</term>
<term>Previous detoxifications</term>
<term>Primary care</term>
<term>Primary care environment</term>
<term>Primary outcome</term>
<term>Primary outcome criterion</term>
<term>Problems questionnaire</term>
<term>Psychosocial</term>
<term>Psychosocial support</term>
<term>Psychosocial therapy</term>
<term>Randomization list</term>
<term>Randomized</term>
<term>Reference values</term>
<term>Regular visits</term>
<term>Rehabilitation programme</term>
<term>Relative benefit</term>
<term>Relative risk</term>
<term>Role limitation dimensions</term>
<term>Role limitations</term>
<term>Routine care</term>
<term>Same time</term>
<term>Seccat survey</term>
<term>Secondary efficacy variables</term>
<term>Secondary outcome measure</term>
<term>Significant difference</term>
<term>Significant differences</term>
<term>Social repercussions</term>
<term>Standard care</term>
<term>Standard care group</term>
<term>Standard practice</term>
<term>Study period</term>
<term>Such patients</term>
<term>Therapeutic objective</term>
<term>Total arpq score</term>
<term>Treatment arms</term>
<term>Treatment effect</term>
<term>Treatment failures</term>
<term>Treatment group</term>
<term>Treatment groups</term>
<term>Unused medication</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Abstinence</term>
<term>Academic centres</term>
<term>Acamprosate</term>
<term>Acamprosate group</term>
<term>Acute detoxification</term>
<term>Additional patient</term>
<term>Adjunctive therapy</term>
<term>Adverse event</term>
<term>Alcohol</term>
<term>Alcohol alcoholism</term>
<term>Alcohol consumption</term>
<term>Alcohol dependence</term>
<term>Alcohol misuse</term>
<term>Alcoholdependent patients</term>
<term>Alcoholdependent subjects</term>
<term>Alcoholism</term>
<term>Ares</term>
<term>Ares study</term>
<term>Arpq</term>
<term>Arpq score</term>
<term>Baseline</term>
<term>Baseline score</term>
<term>Baseline variables</term>
<term>Better outcome</term>
<term>Bodily pain</term>
<term>Clinical effectiveness</term>
<term>Clinical trial methodology</term>
<term>Clinical trials</term>
<term>Community care</term>
<term>Confidence limits</term>
<term>Control group</term>
<term>Cumulative abstinence duration</term>
<term>Cumulative abstinence duration proportion</term>
<term>Detoxification</term>
<term>Diagnostic criteria</term>
<term>Drink diaries</term>
<term>Drinking behaviour</term>
<term>Drinking history</term>
<term>Employment situation</term>
<term>Entry criteria</term>
<term>Everyday practice</term>
<term>Exclusion criteria</term>
<term>Experimental research</term>
<term>Familial antecedents</term>
<term>French version</term>
<term>General population</term>
<term>General practice</term>
<term>General practitioner</term>
<term>General practitioners</term>
<term>Health problems</term>
<term>Health profile measure</term>
<term>Health transition</term>
<term>Inclusion</term>
<term>Inclusion bias</term>
<term>Investigator</term>
<term>Less problem</term>
<term>Medical care</term>
<term>Mental health</term>
<term>Multiple regression analysis</term>
<term>Neat study</term>
<term>Other hand</term>
<term>Outcome criteria</term>
<term>Outcome measure</term>
<term>Outcome measures</term>
<term>Patient characteristics</term>
<term>Patients consulting</term>
<term>Patients randomized</term>
<term>Placebo group</term>
<term>Possible scores</term>
<term>Potential source</term>
<term>Potential sources</term>
<term>Practitioner</term>
<term>Pragmatic</term>
<term>Pragmatic trial</term>
<term>Pragmatic trials</term>
<term>Previous detoxifications</term>
<term>Primary care</term>
<term>Primary care environment</term>
<term>Primary outcome</term>
<term>Primary outcome criterion</term>
<term>Problems questionnaire</term>
<term>Psychosocial</term>
<term>Psychosocial support</term>
<term>Psychosocial therapy</term>
<term>Randomization list</term>
<term>Randomized</term>
<term>Reference values</term>
<term>Regular visits</term>
<term>Rehabilitation programme</term>
<term>Relative benefit</term>
<term>Relative risk</term>
<term>Role limitation dimensions</term>
<term>Role limitations</term>
<term>Routine care</term>
<term>Same time</term>
<term>Seccat survey</term>
<term>Secondary efficacy variables</term>
<term>Secondary outcome measure</term>
<term>Significant difference</term>
<term>Significant differences</term>
<term>Social repercussions</term>
<term>Standard care</term>
<term>Standard care group</term>
<term>Standard practice</term>
<term>Study period</term>
<term>Such patients</term>
<term>Therapeutic objective</term>
<term>Total arpq score</term>
<term>Treatment arms</term>
<term>Treatment effect</term>
<term>Treatment failures</term>
<term>Treatment group</term>
<term>Treatment groups</term>
<term>Unused medication</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Alcool</term>
<term>Alcoolisme</term>
<term>Santé mentale</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Aims: To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treated in a naturalistic setting in primary care in France. Methods: The ARES (Acamprosate et Répercussions Économiques et Sociales; Acamprosate and Economic and Social Repercussions) study was performed by 149 general practitioners interested in treating alcohol use disorders in France who included patients fulfilling DSM-IV criteria for alcohol dependence. The only exclusion criteria concerned contra-indications to acamprosate, co-medication with naltrexone and multiple substance abuse. Eligible patients were randomized to one of two treatment arms, either standard care alone or standard care with acamprosate, using an open-label design and followed up quarterly for a period of 1 year. The primary outcome variable was the change from baseline on the Alcohol-Related Problems Questionnaire. Secondary efficacy variables were abstinence, Clinical Global Impression, quality of life measured with the SF-36 and incidence of adverse events. An intent-to-treat population was used for outcome analysis. Results: 422 patients were included, of whom 348 (82%) completed the protocol as planned. At the end of the study, patients randomized to the acamprosate group had significantly better outcomes in terms of total ARPQ score, change from baseline (−2.61 vs −3.44) and number of subjects with no alcohol-related problem. On average, patients treated with acamprosate had one less alcohol-related problem than did the controls. The number needed to treat in order to save one additional patient from alcohol-related problems compared to standard care was 7.14. Statistically significant differences in favour of the acamprosate group were observed for all secondary efficacy outcome measures including quality of life. Conclusions: Adjunctive therapy with acamprosate in primary care is associated with significantly better functional outcome. Pragmatic trials in alcohol dependence are both feasible and informative.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>France</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Grand Est</li>
<li>Lorraine (région)</li>
<li>Pays de la Loire</li>
<li>Rhône-Alpes</li>
<li>Victoria (État)</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Beaupreau</li>
<li>Lyon</li>
<li>Melbourne</li>
<li>Nancy</li>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Pays de la Loire">
<name sortKey="Kiritze Topor, Paul" sort="Kiritze Topor, Paul" uniqKey="Kiritze Topor P" first="Paul" last="Kiritze Topor">Paul Kiritze Topor</name>
</region>
<name sortKey="Comte, Sylvie" sort="Comte, Sylvie" uniqKey="Comte S" first="Sylvie" last="Comte">Sylvie Comte</name>
<name sortKey="Huas, Dominique" sort="Huas, Dominique" uniqKey="Huas D" first="Dominique" last="Huas">Dominique Huas</name>
<name sortKey="Kiritze Topor, Paul" sort="Kiritze Topor, Paul" uniqKey="Kiritze Topor P" first="Paul" last="Kiritze Topor">Paul Kiritze Topor</name>
<name sortKey="Paille, Franc Ois" sort="Paille, Franc Ois" uniqKey="Paille F" first="Franc Ois" last="Paille">Franc Ois Paille</name>
<name sortKey="Rosenzweig, Claude" sort="Rosenzweig, Claude" uniqKey="Rosenzweig C" first="Claude" last="Rosenzweig">Claude Rosenzweig</name>
</country>
<country name="Australie">
<region name="Victoria (État)">
<name sortKey="Lehert, Philippe" sort="Lehert, Philippe" uniqKey="Lehert P" first="Philippe" last="Lehert">Philippe Lehert</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A972 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A972 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:3BAAC4FBA10894F7FB78A0A7DCD72E3AF5A37F3F
   |texte=   A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024